These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29904327)

  • 1. Pregabalin Misuse and Abuse in Jordan: a Qualitative Study of User Experiences.
    Al-Husseini A; Wazaify M; Van Hout MC
    Int J Ment Health Addict; 2018; 16(3):642-654. PubMed ID: 29904327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregabalin dispensing patterns in Amman-Jordan: An observational study from community pharmacies.
    Al-Husseini A; Abu-Farha R; Wazaify M; Van Hout MC
    Saudi Pharm J; 2018 Mar; 26(3):306-310. PubMed ID: 29556121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community Pharmacists' Perceptions towards the Misuse and Abuse of Pregabalin: A Cross-Sectional Study from Aseer Region, Saudi Arabia.
    Alshahrani SM; Orayj K; Alqahtani AM; Algahtany MA
    Healthcare (Basel); 2021 Sep; 9(10):. PubMed ID: 34682961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary Evidence of Pregabalin Misuse among Prescription and/or Illicit Opioid (Mis)users.
    Buttram ME; Kurtz SP
    J Psychoactive Drugs; 2020; 52(2):172-175. PubMed ID: 32106790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community pharmacists' experience of gabapentin misuse and abuse: A quantitative study from Jordan.
    Ali R; Van Hout MC; Al-Mahaireh M; Wazaify M
    J Ethn Subst Abuse; 2024 Jul; ():1-17. PubMed ID: 38967590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pregabalin Dependence: A Case Report].
    Aldemir E; Altıntoprak AE; Coşkunol H
    Turk Psikiyatri Derg; 2015; 26(3):217-20. PubMed ID: 26364177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative Exploration of the Experiences of People Who Use Captagon and Therapists in Jordan.
    Wazaify M; Al-Khateeb YM; Musleh B; Al-Smadi H; Steenkamp C
    Subst Use Misuse; 2024; 59(5):816-824. PubMed ID: 38263603
    [No Abstract]   [Full Text] [Related]  

  • 8. Reports of gabapentin and pregabalin abuse, misuse, dependence, or overdose: An analysis of the Food And Drug Administration Adverse Events Reporting System (FAERS).
    Evoy KE; Covvey JR; Peckham AM; Ochs L; Hultgren KE
    Res Social Adm Pharm; 2019 Aug; 15(8):953-958. PubMed ID: 31303196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abuse liability of gabapentin in the Saudi population after the pregabalin restriction: A cross-sectional study.
    Alkhalaf AA; Bukhari RA; Alshehri EA; Alshehri SO; Badr AF
    J Taibah Univ Med Sci; 2021 Oct; 16(5):700-705. PubMed ID: 34690650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alarming Pregabalin Abuse in Munich: Prevalence, Patterns of Use and Complications].
    Zellner N; Eyer F; Zellner T
    Dtsch Med Wochenschr; 2017 Sep; 142(19):e140-e147. PubMed ID: 28938502
    [No Abstract]   [Full Text] [Related]  

  • 11. Abuse Potential of Pregabalin: A Systematic Review.
    Schjerning O; Rosenzweig M; Pottegård A; Damkier P; Nielsen J
    CNS Drugs; 2016 Jan; 30(1):9-25. PubMed ID: 26767525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ophthalmic drug abuse: An observational study from community pharmacies.
    Al-Khalaileh W; Abu-Farha R; Wazaify M; Van Hout MC
    Res Social Adm Pharm; 2019 Aug; 15(8):943-948. PubMed ID: 30737195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of Substance Use among Patients in Addiction Rehabilitation in Jordan.
    Yasin H; Bulatova N; Wazaify M
    Subst Use Misuse; 2020; 55(7):1035-1044. PubMed ID: 32013654
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pregabalin and risk of addiction: A new care issue?].
    Roche S; Blaise M
    Encephale; 2020 Oct; 46(5):372-381. PubMed ID: 32471706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Pregabalin - A Nationwide Pharmacoepidemiological Drug Utilization Study with Focus on Abuse Potential.
    Schjerning O; Pottegård A; Damkier P; Rosenzweig M; Nielsen J
    Pharmacopsychiatry; 2016 Jul; 49(4):155-61. PubMed ID: 26951495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregabalin dependence: a case report.
    Halaby A; Kassm SA; Naja WJ
    Curr Drug Saf; 2015; 10(2):184-6. PubMed ID: 25336156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of pregabalin in neurology, psychiatry and addiction: a qualitative overview.
    Martinotti G; Lupi M; Sarchione F; Santacroce R; Salone A; De Berardis D; Serroni N; Cavuto M; Signorelli M; Aguglia E; Valchera A; Iasevoli F; Di Giannantonio M
    Curr Pharm Des; 2013; 19(35):6367-74. PubMed ID: 23782139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abuse and misuse of prescription and nonprescription drugs sold in community pharmacies in Jordan.
    Albsoul-Younes A; Wazaify M; Yousef AM; Tahaineh L
    Subst Use Misuse; 2010 Jul; 45(9):1319-29. PubMed ID: 20509736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disproportionality Analysis for the Assessment of Abuse and Dependence Potential of Pregabalin in the French Pharmacovigilance Database.
    Bossard JB; Ponté C; Dupouy J; Lapeyre-Mestre M; Jouanjus E
    Clin Drug Investig; 2016 Sep; 36(9):735-742. PubMed ID: 27300651
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.